Could CAR t cells slow progressive MS? early trial underway
Disease control
Ongoing
This early-phase study tests a new treatment called KYV-101 in 10 people with progressive multiple sclerosis (MS) whose disease has not responded to standard therapies. The treatment uses a patient's own immune cells, modified to target and potentially calm the immune attack on t…
Phase: PHASE1 • Sponsor: Bruce Cree • Aim: Disease control
Last updated May 26, 2026 10:51 UTC